4//SEC Filing
Gilbert Halley E 4
Accession 0001601360-25-000003
CIK 0001649094other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:10 PM ET
Size
9.2 KB
Accession
0001601360-25-000003
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Gilbert Halley E
Director
Transactions
- Award
Common Stock
2025-06-12+3,041→ 10,216 total - Award
Stock Option (right to buy)
2025-06-12+15,372→ 15,372 totalExercise: $34.46Exp: 2035-06-12→ Common Stock (15,372 underlying)
Holdings
- 13,500
Stock Option (right to buy)
Exercise: $5.35Exp: 2030-04-17→ Common Stock (13,500 underlying)
Footnotes (4)
- [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
- [F2]Option is fully vested and exercisable.
- [F3]On July 25, 2024, Reporting Person transferred 16,874 vested stock options to Reporting Person's ex-spouse pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Accordingly, Reporting Person will not report beneficial ownership of or dispositions or acquisitions of the underlying shares in future Section 16(a) filings.
- [F4]The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001601360
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:10 PM ET
- Size
- 9.2 KB